AzTrials
AzTrials

Critical IllnessNCT04324177

Profile of Pediatric Patients Admitted to AU ICU

An observational study of Critical Illness, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This study aims to determine the profile and outcome of children admitted to ICU at Assiut University children hospital in order to detect association between risk factors and outcome, to asses the efficacy of treatment making it possible to take better decisions , to improve the quality of care. Read more about this study

Who is it for?
Ages 1 month to 18 years
Conditions the study is for
Critical Illness
What is being tested?
Demographic data, morbidity data
How many people
100 participants
Where
No sites listed yet
Study dates
1 Apr 2020to 1 May 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 month to 18 years
  • All sexes
  • Child, Adult

Study population: All patients admitted to the PICU whichever is the diagnosis

Who may be able to join

  • all patients admitted to intensive care unit of Assiut University children hospital over one year aged from 1month to 18 years

Who cannot join

  • pediatric patients less than one month old Pediatric patients will die on arrival

Trial locations and contacts

No sites are listed yet.

Gehad Mahmoud Abdelsalam contact

+201091294596

gehad011157@med.au.edu.eg

Mohammed M. Hamdy Ghazaly contact

+201001296603

mohamed.ghazali1@med.au.edu.eg

About this study

Official title: Profile and Clinical Outcome of Pediatric Patients Admitted to Intensive Care Unit of Assiut University Children Hospital

This study aims to determine the profile and outcome of children admitted to ICU at Assiut University children hospital in order to detect association between risk factors and outcome, to asses the efficacy of treatment making it possible to take better decisions , to improve the quality of care.

Being tested
Demographic data, morbidity data
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Demographic data, morbidity dataOther

    To detect association between the demographic data of pediatric patients including age ,sex,hospital stay and clinical data including the diagnosis and co morbidity with the outcome of pediatric patients admitted to ICU of Assiut University children hospital

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of patients according to age groups and gender

    The demographic data (including age groups and gender).

    Regarding age groups, the number of patients in each of three groups will be addressed:

    1. 1 month to 2 years of age
    2. 2 years to 12 years of age
    3. 12 to 18 years of age"

    Regarding gender, the number of patients will be allocated in 2 groups:

    1. male
    2. female

    Measured: 1 year

  2. Number of patients according to diagnosis on admission

    Provisional diagnosis on admission categorised by the system affected (respiratory, cardiovascular, neurological, hematological, renal, endocrinal and metabolic gastrointestinal and hepatobiliary, multi system affection, others (post operative, post arrest, sepsis syndrome, malignancies, poisoning, coma of unknownorigin)). The data will be presented as number of patients in each group of system affected.

    Measured: 1 year

  3. Number of patients according to referral site

    The patients will be allocated in 2 groups of referral sites of patients admitted to the PICU:

    1. the ward
    2. the emergency department. Data will be presented as number of patients in each group.

    Measured: 1 year

  4. Number of patients according to the need for mechanical ventilation and its duration

    The patients will be allocated in 2 groups based on the need for mechanical ventilation duringthe PICU stay. In case of need for mechanical ventilation, the duration will be recorded in days.

    Measured: 1 year

  5. Length of stay in days

    Length of stay in the pediatric intensive care unit (PICU) will be presented as number of days spent by the patient from admission to discharge or death.

    Measured: 1 year

  6. Pediatric Risk of Mortality score on admission

    Pediatric Risk of Mortlaity (PRISM) III score will be obtained from all patients within the first 24 hours of admission to the PICU. The maximum total PRISM III score is 74. The higher the score, the worse the prognosis. For the analysis of mortality risk factors, patients will be allocated into two groups according to PRISM III 24 score values >8 and ≤ 8, based on previously published data showing increased mortality risk in patients with PRISM III 24 score >8.

    Measured: 1 year

  7. Number of patients according to the condition of discharge from the pediatric intensive care unit

    Number of patients discharged from the PICU allocated in 2 groups:

    1. improvent and transfer to the corresponding medical ward. (Survivors)
    2. death. N.B. patients who will be discharged against medical advice (DAMA) will be excluded from the proposed data analysis, but will be pointed at.

    Measured: 1 year

Secondary outcomes (5)
  1. Correlation 1

    Correlation between number of patients in discharge groups (survivors / dead) and age group.

    Measured: 1 year

  2. Correlation 2

    Correlation between number of patients in discharge groups (survivors / dead) and diagnosis on admission.

    Measured: 1 year

  3. Correlation 3

    Correlation between number of patients in discharge groups (survivors / dead) and length of stay.

    Measured: 1 year

  4. Correlation 4

    Correlation between number of patients in discharge groups (survivors / dead) and PRISM III score.

    Measured: 1 year

  5. Correlation 5

    Correlation between number of patients in discharge groups (survivors / dead) and duration of mechanical ventilation.

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2020
  2. Study start1 Apr 2020 (estimated)
  3. Primary completion30 Mar 2021 (estimated)
  4. Study completion1 May 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04324177
Sponsor's protocol ID
gehad011157
Status last verified
Mar 2020
First submitted
19 Mar 2020
Last updated
27 Mar 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Haftu H, Hailu T, Medhaniye A, G/Tsadik T. Assessment of pattern and treatment outcome of patients admitted to pediatric intensive care unit, Ayder Referral Hospital, Tigray, Ethiopia, 2015. BMC Res Notes. 2018 May 24;11(1):339. doi: 10.1186/s13104-018-3432-4.

    PubMed 29793551
  • Khilnani P, Sarma D, Singh R, Uttam R, Rajdev S, Makkar A, Kaur J. Demographic profile and outcome analysis of a tertiary level pediatric intensive care unit. Indian J Pediatr. 2004 Jul;71(7):587-91. doi: 10.1007/BF02724117.

    PubMed 15280607

Questions about this trial

What is this clinical trial studying?

An observational study of Critical Illness, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Mar 2020. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Gehad Mahmoud Abdelsalam (+201091294596, gehad011157@med.au.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of patients according to age groups and gender (time frame: 1 year). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04324177, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in